Fresh analysis indicates that people who come off popular slimming jabs like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.
Published data in a prominent medical journal demonstrates that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Users purchasing these drugs need to be cognizant of the risk of quick weight regain when the medication is stopped," stated researcher Dr. Susan Jebb.
That rate of regain implies a reversion to pre-treatment mass in about a year and a half.
Weighing Therapies
The analysis, which reviewed dozens of trials involving thousands of patients, compared the effects of GLP-1 agonists with older methods.
The team point out that individuals who shed pounds through diet and exercise usually see a slower weight regain—around 0.1 kg a month—after stopping.
Explaining the Fast Rebound
Nutrition scientists suggest the mechanism of the drugs is key to understanding the heightened weight return.
GLP-1 drugs mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' results in appetite is unsuppressed, making overeating far more likely."
A Chronic Disease?
The NHS recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, due to the high risk of relapse, the treatment might need to be ongoing.
This view is supported by pharmaceutical companies, who say that the results "emphasize the long-term character of obesity," comparing it to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the jabs describe a intense resurgence of cravings.
"It felt as if a trigger that goes on and you become starving," described a patient.
The struggle is worsened if individuals have not established sustainable dietary or behavioural changes during treatment.
Growing Adoption
Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is higher among females than males.
- The middle-aged demographic shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a magic cure and long-term success hinges on ongoing behavioural management.
